Menu

Jumping Genes Inactivated with CRISPR in Pigs

The study could pave the way for transplanting porcine organs to humans without the risk of reigniting endogenous retroviruses.

Aug 10, 2017
Shawna Williams

Piglets whose genes were altered using CRISPREGENESISThe gene-editing technique CRISPR-Cas9 has received ample attention for its potential to improve human health via gene therapy. Today (August 10), an international team of researchers announced a step toward giving it an entirely different role in medicine: enabling xenotransplantation—in this case, of pig organs into humans. As reported in Science, the group used CRISPR to disable viral DNA lodged in the pig genome and then grew healthy piglets from the edited cells.

Pig organs are about the same size as humans,’ so some scientists and transplant surgeons see them as candidates to solve the problem of a shortage of organ donors, reports The New York Times. Previous experiments have worked toward customizing pig organs to make them compatible with human recipients. But one concern has been the potential for the zombies of pig infections past, known as porcine endogenous retroviruses (PERVs), to reanimate and infect human organ recipients.

See “Scientists Create First Human-Pig Chimeric Embryos”

The research group identified 25 PERVs in pig genomes, then used CRISPR-Cas9 to inactivate all of them. They inserted the edited genetic material into pig eggs to create embryos, which were implanted in sows and developed into piglets, reports New Scientist.

“This research represents an important advance in addressing safety concerns about cross-species viral transmission,” study author Luhan Yang of the biotech company eGenesis tells The Guardian. “Our team will further engineer the Perv-free pig strain to deliver safe and effective xenotransplantation.”

The New York Times notes that patients with diabetes have been treated with pig pancreatic cells, and burn victims with pig skin grafts, with no apparent problems so far caused by PERVs.

Jay Fishman, co-director of the transplant program at Massachusetts General Hospital, questions whether PERVs were really so dangerous in the first place. “We don’t know that if we transplant pig organs with the viruses that they will transmit infections, and we don’t know that the infections are dangerous,” he tells the Times. “I think the risk to society is very low.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing
Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies. This new range of recombinant monoclonal antibodies, directed against the three main mouse isotypes: IgG1, IgG2a, and IgG2b, offer improved signal detection and specificity in imaging, ELISA, flow cytometry, and western blotting.